Articles dans des revues avec comité de lecture (262)
122.
Bousser, M., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K., Hennerici, M., Mattle, H., Rothwell, P., PERFORM Study Investigators,, & Pandolfo, M. (2009). Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular diseases, 27(5), 509-518. doi:10.1159/000212671123.
Goole, J., Van Gansbeke, B., Pilcer, G., Deleuze, P., Blocklet, D., Goldman, S., Pandolfo, M., Vanderbist, F., & Amighi, K. (2008). Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. International journal of pharmaceutics, 364(1), 54-63. doi:10.1016/j.ijpharm.2008.08.016125.
Diener, H.-C., Sacco, R. L., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., Gu, V., Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., Yoon, B.-W., Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group,, & Pandolfo, M. (2008). Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet neurology, 7(10), 875-884. doi:10.1016/S1474-4422(08)70198-4126.
Schmitz-Hübsch, T., Coudert, M., Bauer, P., Giunti, P., Globas, C., Baliko, L., Filla, A., Mariotti, C., Rakowicz, M., Charles, P., Ribai, P., Szymanski, S., Infante, J., van de Warrenburg, B. P., Dürr, A., Timmann, D., Boesch, S., Fancellu, R., Rola, R., Depondt, C., Schöls, L., Zdienicka, E., Kang, J.-S., Döhlinger, S., Kremer, B., Stephenson, D. A., Melegh, B., Pandolfo, M., di Donato, S., du Montcel, S. T., & Klockgether, T. (2008). Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology, 71(13), 982-989. doi:10.1212/01.wnl.0000325057.33666.72127.
Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., Gu, V., Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., Yoon, B.-W., PRoFESS Study Group,, & Pandolfo, M. (2008). Telmisartan to prevent recurrent stroke and cardiovascular events. The New England journal of medicine, 359(12), 1225-1237. doi:10.1056/NEJMoa0804593128.
Sacco, R. L., Diener, H.-C., Yusuf, S., Cotton, D., Ounpuu, S., Lawton, W. A., Palesch, Y., Martin, R., Albers, G. W., Bath, P., Bornstein, N., Chan, B. P., Chen, S.-T., Cunha, L., Dahlöf, B., De Keyser, J., Donnan, G. A., Estol, C., Gorelick, P., Gu, V., Hermansson, K., Hilbrich, L., Kaste, M., Lu, C., Machnig, T., Pais, P., Roberts, R., Skvortsova, V., Teal, P., Toni, D., VanderMaelen, C., Voigt, T., Weber, M., Yoon, B.-W., PRoFESS Study Group,, & Pandolfo, M. (2008). Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England journal of medicine, 359(12), 1238-1251. doi:10.1056/NEJMoa0805002129.
Abboud, S., Viiri, L. E., Lütjohann, D., Goebeler, S., Luoto, T., Friedrichs, S., Desfontaines, P., Gazagnes, M.-D., Laloux, P., Peeters, A., Seeldrayers, P., Lehtimaki, T., Karhunen, P. J., Pandolfo, M., & Laaksonen, R. (2008). Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. European journal of human genetics, 16(8), 955-960. doi:10.1038/ejhg.2008.27131.
McNeill, A., Pandolfo, M., Kuhn, J., Shang, H., & Miyajima, H. (2008). The neurological presentation of ceruloplasmin gene mutations. European neurology, 60(4), 200-205. doi:10.1159/000148691132.
Rai, M., Soragni, E., Jenssen, K., Burnett, R., Herman, D., Coppola, G., Geschwind, D. H., Gottesfeld, J. M., & Pandolfo, M. (2008). HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PloS one, 3(4), e1958. doi:10.1371/journal.pone.0001958